Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion.
about
Strategies for combining immunotherapy with radiation for anticancer therapyRadiation-induced immune responses: mechanisms and therapeutic perspectivesImmunobiology of radiotherapy: new paradigmsIrradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α.Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow "in situ tumor vaccination"?
P2860
Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@ast
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@en
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@nl
type
label
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@ast
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@en
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@nl
prefLabel
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@ast
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@en
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@nl
P2093
P2860
P356
P1433
P1476
Treatment of 4T1 metastatic br ...... nd autologous T-cell infusion.
@en
P2093
Alexander Filatenkov
Antonia M Müller
Edgar G Engleman
Holbrook Kohrt
Jeanette Baker
Judith A Shizuru
Kent Jensen
Robert S Negrin
Samuel Strober
P2860
P304
P356
10.1667/RR13471.1
P50
P577
2014-07-03T00:00:00Z